Page 96 - Roche Diagnostics News Today

 E-Mail (Boston)--Atrial fibrillation (AF) is associated with a higher risk of complications including ischemic stroke, cognitive decline, heart failure, myocardial infarction and death. AF frequently is undetected until complications such as stroke or heart failure occur. While the public and clinicians have an intense interest in detecting AF earlier, the most appropriate strategies to detect undiagnosed AF and medical prognosis and therapeutic implications of AF detected by screening are u...

The Elecsys Anti-SARS-CoV-2 S targets antibodies, which are directed against the particular region of the viral spike protein responsible for binding to the host cell receptor, which is required for the virus to enter the host cell

In-Vitro Diagnostics Market Segmented by End-user Industry and Geography – Growth, Trends, and Forecast (2020 – 2027)

FinancialContent fully hosted finance channel

The growing incidence of cardiovascular diseases, rapidly increasing geriatric population, growing funding from public and private organizations for research on cardiac biomarkers, and ongoing clinical trials for the identification of novel cardiac biomarkers. However, factors such as technical problems related to sample collection and storage and issues related to regulatory and reimbursement systems are expected to restrain market growth to a certain extent. The cardiac marker testing market ...

Cardiac Marker Testing Market worth $5.5 billion by 2025 - Exclusive Report by MarketsandMarkets "Cardiac Marker Testing Market by Product (Reagent, Instrument), Component (Troponin I & T, CK-MB, Myoglobin, BNP, hsCRP), Disease (Myocardial Infarction, Congestive Heart Failure, Atheresclerosis), Enduser (Lab, PoC, Academia) - Global Forecasts to 2025", published by MarketsandMarkets, the market is estimated to be USD 3.6 billion in 2020 and projected to reach USD 5.5 billion by 2025, at a CAGR ...

Test Strip Market Size, Share, Trends Analysis & Competition Through 2025

/PRNewswire/ -- According to the new market research report "Albumin & Creatinine Tests Market by Product (Analyzers, Cartridges (PoC, Tabletop), Dipsticks,...

Albumin & Creatinine Tests Market worth $2,103 million by 2025 - Exclusive Report by MarketsandMarkets "Albumin & Creatinine Tests Market by Product (Analyzers, Cartridges (PoC, Tabletop), Dipsticks, Kits, Reagents), Type (Blood & Urine Creatinine, Urine Albumin, Glycated Albumin), Enduser (Hospital, Diagnostic & Research Labs) - Global Forecast to 2025", published by MarketsandMarkets, the ACR Test Market is projected to reach USD 2,103 million by 2025 from USD 987 million in 2020, at a CAGR ...

Jan 14, 2021 Differing demographic characteristics appear to determine trial participation Brand new parents who agreed to enroll their infants in a neonatal clinical trial differed from those who declined participation in terms of self-identified race/ethnicity, income, and insurance coverage, researchers reported. In a survey-based study of 369 parents, those who placed the infant in the HEAL study had lower rates of Medicaid participation (41.1% versus 55.3%, P=0.04) and higher rates of ann...